序号 | 纳入研究 | 例数 (T/C) | 平均年龄 (T/C,岁) | 性别 (男/女) | 病程 (T/C,年) | 干预措施 | 疗程/周 | 结局指标 | |
T | C | ||||||||
1 | 欧秋明2015 [8] | 60/60 | 39.5 ± 7.8/38.9 ± 8.2 | 63/57 | 9.0 ± 3.4/9.4 ± 3.7 | A + C | B + C | 8 | ①②③⑤ |
2 | 解凯2016 [9] | 30/30 | 不清楚 | 33/27 | 0.5~3.8 | A + D | B + D | 8 | ①②③⑤ |
3 | 李元梅2017 [10] | 64/64 | 32.6 ± 2.5/32.1 ± 2.2 | 71/57 | 1.2 ± 0.5/1.3 ± 0.5 | A + C | B + C | 10 | ①②③⑤ |
4 | 刘玉路2017 [11] | 55/55 | 39.4 ± 7.6/38.8 ± 8.1 | 69/41 | 不清楚 | A + D | B + D | 8 | ①②③⑤ |
5 | 邢莉2018 [12] | 30/30 | 32.9 ± 5.4/32.2 ± 5.2 | 37/23 | 1.2 ± 0.9/1.7 ± 1.4 | A + C | B + C | 8 | ①③⑤ |
6 | 农玉贤2018 [13] | 25/25 | 35.6 ± 3.3 | 33/17 | 1.6 ± 0.4 | A + C | B + C | 10 | ①②③⑤ |
7 | 茹先古力·萨吾提 2018 [14] | 30/30 | 41.3 ± 3.5 | 38/22 | 2.5 ± 1.2 | A + D | B + D | 8 | ①③⑤ |
8 | 王龙2018 [15] | 39/39 | 33.3 ± 2.4/32.9 ± 2.6 | 43/35 | 1.2 ± 0.2/1.5 ± 0.3 | A + D | B + D | 9 | ①③⑤ |
9 | 薛李2019 [16] | 36/36 | 52.3 ± 6.8/51.6 ± 7.1 | 33/39 | 不清楚 | A + C | B + C | 8 | ①②③④ |
10 | 钟笑2019 [17] | 30/30 | 57.3 ± 3.2 | 34/26 | 5.5 ± 1.2 | A + C | B + C | 8 | ①③④⑤ |
11 | 张红胜2020 [18] | 40/40 | 42.2 ± 2.4/42.8 ± 2.5 | 38/32 | 不清楚 | A + D | B + D | 12 | ①③④⑤ |